Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michelle C Alozie"'
Autor:
Alexandra McLean Stevens, Maci Terrell, Raushan Rashid, Jaime Omar Munoz, Alan K Gonzalez, Hailey H Oviedo, Tamilini Ilangovan, Michelle C Alozie, Michael Krueger, Kevin E. Fisher, Michele S. Redell
Publikováno v:
Blood. 140:11807-11808
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b02203846916faf8dd64f93aeeb1eb5
https://doi.org/10.1182/blood-2022-170348
https://doi.org/10.1182/blood-2022-170348
Autor:
Debbie C. Strachan, Christine J. Gu, Ryosuke Kita, Erica K. Anderson, Michelle A. Richardson, George Yam, Graham Pimm, Jordan Roselli, Alyssa Schweickert, Maci Terrell, Raushan Rashid, Alan K. Gonzalez, Hailey H. Oviedo, Michelle C. Alozie, Tamilini Ilangovan, Andrea N. Marcogliese, Hiroomi Tada, Marianne T. Santaguida, Alexandra M. Stevens
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6240
Acute myeloid leukemia (AML) is a heterogeneous disease that accounts for ~20% of all childhood leukemias, and more than 40% of children with AML relapse within three years of diagnosis. Although recent efforts have focused on developing a precise me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f07aba0a4a88ba41940b90b378f763
https://doi.org/10.3390/cancers14246240
https://doi.org/10.3390/cancers14246240
Autor:
Eunji Jo, Alicia E. Mangubat-Medina, Allison Weisnicht, Cara A Rabik, Susan G. Hilsenbeck, Todd M. Cooper, Hana Paek, Michelle C Alozie, Alexandra M. Stevens, Zachary T. Ball, Michele S. Redell, Minhua Li, Hailey H Oviedo, Alan K Gonzalez, Claire E. Bocchini, Haopei Wang, Maci Terrell, Raushan Rashid, Noah J Keogh, Eric S. Schafer
Publikováno v:
Blood. 138:2312-2312
Background Relapse free survival of pediatric AML remains only 60%. Current standard myelosuppressive therapy has been maximized, so novel therapies with minimal toxicities are needed to improve outcomes. Previously, we found atovaquone (AQ), an FDA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0334ccefb5db8ce34b0c410aadef4e6
https://doi.org/10.1182/blood-2021-146057
https://doi.org/10.1182/blood-2021-146057
Autor:
Hailey H Oviedo, Christine Gu, Erica K. Anderson, Ryosuke Kita, Debbie C. Strachan, Michelle C Alozie, Alan K Gonzalez, Noah J Keogh, Alexandra M. Stevens, Raushan Rashid, Michelle A Richardson, Andrea N. Marcogliese, Maci Terrell, Marianne Santaguida
Publikováno v:
Blood. 138:2361-2361
Background Pediatric acute myeloid leukemia (AML) is a rare disease with roughly 600 cases diagnosed in the United States each year with minimal improvement in clinical outcomes over the last few decades. We previously demonstrated that an ex vivo dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d3876be895ce4297af19d6b111a00b5
https://doi.org/10.1182/blood-2021-145275
https://doi.org/10.1182/blood-2021-145275